Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 08, 2026 08:34 ET | Source: The Ritedose Corporation

Ritedose Announces Manufacturing for Tenpoint Therapeutics’ Presbyopia Eye Drop

Ritedose partners with Tenpoint Therapeutics to manufacture YUVEZZI™, the first FDA-approved dual-action eye drop for presbyopia.
October 30, 2025 08:23 ET | Source: The Ritedose Corporation

Ritedose Now Offers the Largest Nebulized Drug Portfolio in the U.S.: FDA Approves the Company to Manufacture Generic Tobramycin Inhalation Solution

With the addition of Tobramycin Inhalation Solution, Ritedose now provides the largest nebulized drug portfolio in the country.